Clinical trial
Serum Soluble B-cell Maturation Antigen as a Non-Invasive Marker in Multiple Myeloma
NCT07855718 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Serum Soluble B-cell Maturation Antigen as a Non-Invasive Marker in Multiple Myeloma
- Lead sponsor
- Assiut University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- September 30, 2026
- Completion date
- February 10, 2028
- Enrollment
- 90 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.